Twitxy Saved

Dr. E. L. Stone

@StoneEL2

#PhD #Tcells #Immunotherapy #TumorImmunity #Immunology Tweets are my opinion, retweets not endorsement. Recovering academic. she/her. Now design Next-Gen CPIs.
San Francisco, CA Joined June 2018
4K Following 2.3K Followers 5K Posts

Latest posts 5

Pinned post

Dr. E. L. Stone @StoneEL2

Replying to @StoneEL2

(4) Nextgen IL2s w reduced binding to CD25, induce less Treg proliferation and have had encouraging results in trials.

Our third-gen anti-CTLA-4 with limited ability to block CTLA-4 induces less Treg proliferation, has enhanced anti-tumor efficacy but reduced toxicity in models
Dr. E. L. Stone @StoneEL2
Excited to be at @AACR to help share the first clinical data for GIGA-564, a differentiated, non-blocking anti-CTLA-4 mAb designed to deplete intratumoral Tregs, including a favorable safety profile and monotherapy RECISTv1.1 responses.

#AACR2026

grifols.com/en/view-news/-…
www.grifols.com GigaGen presents positive phase 1 data on non-blocking anti-CTLA-4 drug candidate GIGA-564 at AACR... Stay updated with the latest news from Grifols. Access important media contacts and insights in the pharmaceutical sector for informed communication.